Endosulfan

CASRN 115-29-7

Health Hazard Assessments for Effects Other than Cancer


Reference Dose for Oral Exposure (RfD) (PDF) (15 pp, 122 K) last updated: 10/01/1994

RfD (mg/kg-day) System Basis PoD Composite UF Confidence
6 x10-3 Urinary, Cardiovascular, Other Reduced body weight gain in males and females increased incidence of marked progressive glomerulonephrosis and blood vessel aneurysms in males NOAEL : 6 x10-1
mg/kg-day
100 Medium

Reference Concentration for Inhalation Exposure (RfC) (PDF) (15 pp, 122 K)
Not assessed under the IRIS Program.

Cancer Assessment


Weight of Evidence for Cancer (PDF) (15 pp, 122 K)
Not assessed under the IRIS Program.

Quantitative Estimate of Carcinogenic Risk from Oral Exposure (PDF) (15 pp, 122 K)

Not assessed under the IRIS Program.

Quantitative Estimate of Carcinogenic Risk from Inhalation Exposure (PDF) (15 pp, 122 K)

Not assessed under the IRIS Program.

You will need Adobe Reader to view some of the files on this page. See EPA’s PDF page to learn more.